Compare Cytokinetics Inc (CYTK) vs Strategy Inc. (MSTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Strategy Inc. — how do they compare? Cytokinetics Inc trades at $82.03 (market cap $11.16B), while Strategy Inc. trades at $98.17 (market cap $33.40B). The key difference: Strategy Inc. is far larger — about 3× Cytokinetics Inc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Strategy Inc. nearer its low. Which is the better fit depends on your goals.
| CYTK | MSTR | |
|---|---|---|
Market Cap | $11.16B | $33.40B |
Sector | Technology | Technology |
52-Week High | $87.26 | $455.90 |
52-Week Low | $33.23 | $82.31 |
Enterprise Value | $11.63B | $48.43B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →
